Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the notice about a lapse in government funding as well as the previous Revision: v3.4.1 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T06:15:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide government-funding lapse notice regarding NIH operations. Updated the page to Revision: v3.4.1 (replacing v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-04T05:43:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T04:01:03.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Key documents such as the Statistical Analysis Plan and the Study Protocol were removed from the Study Documents section.
    Difference
    16%
    Check dated 2026-01-21T02:50:53.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and deleted Revision: v3.3.3 for the study documents, reflecting a minor version update.
    Difference
    0.0%
    Check dated 2026-01-14T01:50:41.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Consolidated Locations section now lists study sites across multiple regions (US states and international sites such as Alberta, Ontario, Quebec, and Málaga), replacing the previous state-by-state location blocks. This change improves visibility of where the study is conducted and affects how users identify nearby sites.
    Difference
    1%
    Check dated 2025-12-23T10:18:09.000Z thumbnail image

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.